Robeco Institutional Asset Management B.V. Biomarin Pharmaceutical Inc Transaction History

Robeco Institutional Asset Management B.V.

  • $50.6 Billion
  • Q1 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 97,261 shares of BMRN stock, worth $5.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
97,261
Previous 86,574 12.34%
Holding current value
$5.59 Million
Previous $5.69 Million 20.83%
% of portfolio
0.01%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025
BUY
$61.25 - $72.83 $654,578 - $778,334
10,687 Added 12.34%
97,261 $6.88 Million
Q4 2024

Jan 22, 2025
SELL
$61.93 - $70.49 $7.69 Million - $8.75 Million
-124,092 Reduced 58.9%
86,574 $5.69 Million
Q3 2024

Oct 29, 2024
BUY
$69.02 - $93.84 $8.89 Million - $12.1 Million
128,807 Added 157.35%
210,666 $14.8 Million
Q2 2024

Jul 22, 2024
BUY
$74.43 - $92.22 $1.97 Million - $2.44 Million
26,481 Added 47.82%
81,859 $6.74 Million
Q1 2024

Apr 24, 2024
BUY
$83.81 - $99.0 $3.47 Million - $4.1 Million
41,381 Added 295.64%
55,378 $4.84 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $9,298 - $12,018
122 Added 0.88%
13,997 $1.35 Million
Q4 2023

Feb 08, 2024
SELL
$76.22 - $98.51 $860,676 - $1.11 Million
-11,292 Reduced 44.87%
13,875 $14 Million
Q3 2023

Oct 23, 2023
SELL
$85.07 - $94.48 $258,868 - $287,502
-3,043 Reduced 10.79%
25,167 $2.23 Million
Q2 2023

Jul 24, 2023
SELL
$86.68 - $100.3 $580,322 - $671,508
-6,695 Reduced 19.18%
28,210 $2.45 Million
Q1 2023

May 03, 2023
BUY
$87.74 - $117.27 $407,113 - $544,132
4,640 Added 15.33%
34,905 $3.39 Million
Q4 2022

Feb 06, 2023
SELL
$80.93 - $108.63 $2.21 Million - $2.96 Million
-27,269 Reduced 47.4%
30,265 $3.13 Million
Q3 2022

Dec 01, 2022
BUY
$82.16 - $96.94 $315,658 - $372,443
3,842 Added 7.16%
57,534 $4.88 Million
Q3 2022

Oct 26, 2022
BUY
$82.16 - $96.94 $315,658 - $372,443
3,842 Added 7.16%
57,534 $4.88 Million
Q2 2022

Dec 01, 2022
BUY
$71.48 - $86.85 $283,060 - $343,926
3,960 Added 7.96%
53,692 $4.45 Million
Q2 2022

Jul 27, 2022
BUY
$71.48 - $86.85 $283,060 - $343,926
3,960 Added 7.96%
53,692 $4.45 Million
Q1 2022

Dec 01, 2022
BUY
$74.28 - $92.69 $3.47 Million - $4.33 Million
46,705 Added 1542.95%
49,732 $3.83 Million
Q1 2022

Apr 26, 2022
BUY
$74.28 - $92.69 $3.47 Million - $4.33 Million
46,705 Added 1542.95%
49,732 $3.83 Million
Q4 2021

Dec 01, 2022
BUY
$71.72 - $91.47 $2,366 - $3,018
33 Added 1.1%
3,027 $268,000
Q4 2021

Jan 31, 2022
BUY
$71.72 - $91.47 $2,366 - $3,018
33 Added 1.1%
3,027 $268,000
Q3 2021

Dec 01, 2022
SELL
$74.77 - $85.47 $385,663 - $440,854
-5,158 Reduced 63.27%
2,994 $231,000
Q3 2021

Oct 20, 2021
SELL
$74.77 - $85.47 $385,663 - $440,854
-5,158 Reduced 63.27%
2,994 $231,000
Q2 2021

Dec 01, 2022
SELL
$75.51 - $84.79 $390,613 - $438,618
-5,173 Reduced 38.82%
8,152 $680,000
Q2 2021

Jul 28, 2021
SELL
$75.51 - $84.79 $390,613 - $438,618
-5,173 Reduced 38.82%
8,152 $680,000
Q1 2021

Dec 01, 2022
SELL
$74.73 - $90.69 $3.3 Million - $4.01 Million
-44,209 Reduced 76.84%
13,325 $1.01 Million
Q1 2021

Apr 23, 2021
SELL
$74.73 - $90.69 $996,300 - $1.21 Million
-13,332 Reduced 50.01%
13,325 $1.01 Million
Q4 2020

Dec 01, 2022
SELL
$72.61 - $90.2 $2.24 Million - $2.79 Million
-30,877 Reduced 53.67%
26,657 $2.34 Million
Q4 2020

Jan 28, 2021
SELL
$72.61 - $90.2 $1.52 Million - $1.89 Million
-20,937 Reduced 43.99%
26,657 $2.34 Million
Q3 2020

Oct 29, 2020
SELL
$71.87 - $131.03 $787,407 - $1.44 Million
-10,956 Reduced 18.71%
47,594 $3.62 Million
Q2 2020

Jul 20, 2020
BUY
$79.55 - $124.22 $4.34 Million - $6.78 Million
54,605 Added 1384.16%
58,550 $7.22 Million
Q1 2020

Apr 30, 2020
BUY
$71.37 - $96.85 $9,991 - $13,559
140 Added 3.68%
3,945 $333,000
Q4 2019

Feb 06, 2020
SELL
$64.27 - $86.37 $203,350 - $273,274
-3,164 Reduced 45.4%
3,805 $321,000
Q3 2019

Oct 17, 2019
BUY
$67.4 - $85.11 $151,178 - $190,901
2,243 Added 47.46%
6,969 $469,000
Q1 2019

May 02, 2019
BUY
$84.2 - $98.62 $131,520 - $154,044
1,562 Added 49.37%
4,726 $419,000
Q4 2017

Jan 25, 2018
BUY
$80.76 - $95.13 $255,524 - $300,991
3,164
3,164 $282,000

Others Institutions Holding BMRN

# of Institutions
668
Shares Held
184M
Call Options Held
1.24M
Put Options Held
957K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.7B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email